How to Help Your Patients Save Money on HSV-1 Antivirals: A Provider's Guide to Savings Programs

Medication cost is a significant barrier to HSV-1 antiviral adherence. For patients on daily suppressive therapy, even a modest copay or cash price can create adherence challenges — and non-adherence means more outbreaks, more transmission risk, and more clinical burden. This guide equips prescribers and care teams with practical tools to help patients access HSV-1 antiviral medications affordably in 2026.

The Cost Landscape for HSV-1 Antivirals in 2026

Understanding the cost landscape helps you counsel patients appropriately:

• Generic acyclovir 400 mg (60 tablets) retail: $70–$105 without insurance; $10–$15 with GoodRx or SingleCare; as low as $4/month through Walmart's program
• Generic valacyclovir 500 mg (30 tablets) retail: $100–$217 without insurance; approximately $21.90 with GoodRx coupon (79% off retail)
• With insurance: Both generics are Tier 1–2 on most plans; copays typically $0–$30 per 30-day supply
• Brand Valtrex: ~$472 for 30 tablets 500 mg retail; almost never clinically necessary given identical generic efficacy

Strategy 1: Default to Generic — Always

The simplest cost intervention is ensuring you always prescribe generic acyclovir or generic valacyclovir (not brand Zovirax or brand Valtrex). In the U.S., prescriptions are often DAW-0 (dispense as written), but ensure your EHR defaults to generics. Generic valacyclovir costs 79–90% less than brand Valtrex with no difference in efficacy. Explicitly educate patients that the generic is identical in active ingredient, dose, and effect.

Strategy 2: Teach Patients to Use Discount Cards

Many patients don't know that prescription discount cards can reduce costs dramatically — even below their insurance copay in some cases. Consider providing a resource card in your office listing:

• GoodRx (goodrx.com): Acyclovir 400 mg 60-tab: ~$10–$15; Valacyclovir 500 mg 30-tab: ~$21.90
• SingleCare (singlecare.com): Similar to GoodRx; prices vary by pharmacy — worth comparing both
• Optum Perks: Available at many pharmacies; competitive pricing

Note: Patients cannot use a discount card and insurance at the same time. They should compare the discount card price versus their insurance copay and choose whichever is lower.

Strategy 3: Direct Patients to Walmart Pharmacy and Cost Plus Drugs

For uninsured patients, two pharmacy programs offer especially low acyclovir prices:

• Walmart $4/$10 Prescription Program: Includes certain acyclovir formulations — $4 for 30-day supply, $10 for 90-day supply. No membership needed to use the pharmacy.
• Cost Plus Drugs (costplusdrugs.com): Near-wholesale pricing on generics with home delivery. An excellent option for patients on daily suppressive therapy who want a reliable, low-cost mail-order supply.

Strategy 4: Prescribe 90-Day Supplies

Prescribing a 90-day supply for patients on suppressive therapy:

• Reduces per-unit cost (pharmacies charge less per pill for larger quantities)
• Reduces pharmacy trips and dispensing fees (3 fees per year vs. 12)
• Many insurance plans offer lower copays for 90-day mail-order fills than for 30-day retail fills
• Reduces shortage risk — a 90-day supply buffer means one pharmacy being temporarily out of stock doesn't interrupt therapy

Strategy 5: Check Formulary Coverage and Switch If Needed

If a patient has high out-of-pocket costs for their current antiviral prescription, their insurance may have a preferred formulary alternative at a lower tier. Both generic acyclovir and generic valacyclovir are Tier 1–2 on most formularies. If a patient is on famciclovir at a higher tier and cost is an issue, switching to valacyclovir or acyclovir may significantly reduce their copay. Check the patient's specific plan formulary before the next refill.

Strategy 6: Connect Uninsured or Low-Income Patients to PAPs

For patients with significant financial hardship, patient assistance programs (PAPs) may help:

• NeedyMeds.org: Comprehensive database of manufacturer and non-manufacturer assistance programs; search by medication name
• RxAssist.org: Another database connecting patients with pharmaceutical assistance programs
• Planned Parenthood and community health centers: Provide sliding-scale fee services including antiviral prescriptions for uninsured patients

The Clinical Case for Addressing Cost Proactively

Non-adherence to suppressive antiviral therapy has real clinical consequences: more frequent outbreaks, higher risk of HSV transmission to partners, greater psychological burden, and in pregnant patients, increased risk of neonatal HSV exposure. The downstream clinical costs of non-adherence far exceed the cost of the medication. A brief conversation at each visit about medication affordability and available programs is a high-value intervention.

Supporting Patients Through Finding Medication

When patients can't find their antiviral in stock, cost savings are irrelevant. Directing patients to medfinder for providers helps them locate pharmacies with their medication in stock, reducing the calls that come back to your office. For a complete guide to helping patients find medications in stock during shortage conditions, see our provider guide to helping patients find HSV-1 antivirals in stock.